<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-vaccines-08-00115">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Franceschi</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Capocefalo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Calvo-Pinilla</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Redaelli</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mucignat-Caretta</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mertens</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Ortego</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Donofrio</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Immunization of knock-out alpha/beta interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen</article-title>
  <source>Vaccine</source>
  <year>2011</year>
  <volume>29</volume>
  <fpage>3074</fpage>
  <lpage>3082</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.01.075</pub-id>
  <pub-id pub-id-type="pmid">21320537</pub-id>
 </element-citation>
</ref>
